Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

PolyU makes great strides in developing cancer drugs

09.04.2009
The Hong Kong Polytechnic University has achieved further breakthrough in developing cancer drugs. The innovation has recently been awarded at the 37th International Exhibition of Inventions, New Techniques and Products of Geneva.

The Hong Kong Polytechnic University (PolyU) has achieved further breakthrough in developing cancer drugs through making use of advanced biotechnology. This breakthrough not only gives a ray of hope for cancer patients, but also revolutionizes the concept of cancer drug development.

This innovation has recently been awarded the Prize of the State of Geneva (third runner-up prize) and a Gold Medal with Jury’s Commendation at the 37th International Exhibition of Inventions, New Techniques and Products of Geneva.

Developed by Associate Professor Dr Thomas Leung Yun-chung and Assistant Professor Dr Thomas Lo Wai-hung of the University's Department of Applied Biology and Chemical Technology, the new drugs work on the mechanism of starving cancer cells through depletion of arginine - a key nutrient for many cancer cells.

PolyU researchers have proved that the depletion or lowering of blood arginine concentrations is effective in inhibiting the proliferation of liver cancer. The research paper on this important finding was first published in the authoritative, highly cited journal Cancer Research, published by the American Association for Cancer Research (January 2007 issue). This paper has shed new light on the development of novel arginine-depleting cancer drug for treating liver cancer (hepatocellular carcinoma).

The main constituent of this new drug is arginase, an enzyme that degrades arginine, with urea as an end-product. However, naturally occurring arginase has a very short half-life and thus cannot be used for therapeutic purpose. Using state-of-the-art DNA technology, PolyU researchers produced in 2005 a recombinant human arginase that, after chemical modification, has a significantly prolonged half-life for therapeutic use. More recently, they have further invented a novel drug based on naturally occurring thermostable Bacillus arginase (BCA). A patent application has been filed for this novel drug.

This breakthrough has a far-reaching impact in that the second generation of cancer drugs developed by PolyU researchers could provide a cure not just for liver cancer, but also for other deadly cancer diseases. In the laboratory settings, the new drug has been proved to work in cell culture for breast cancer, cervical cancer, skin cancer, pancreatic cancer, lung cancer, colorectal cancer, and gastric cancer.

Pre-clinical studies conducted on the use of this drug in nude mice showed that the drug is effective in depleting blood arginine and inhibiting breast cancer. The use of this new drug has opened up many new opportunities for effective treatment of different types of cancer. As this anti-cancer therapy is a targeted approach, it only affects cancer cells but not normal cells, causing less side effects than traditional cytotoxic chemotherapy.

Furthermore, the new drug is more stable with a longer blood circulating half-life, which means cancer patients can receive fewer injections of smaller amounts of this drug to achieve the same result. The new drug is also purer because of its homogenous structure and the production cost is expected to be lower because of its simple form.

The first generation of cancer drug based on arginine depletion has been proved to work on liver cancer and is now going through the clinical trial stages with the support of Queen Mary Hospital and the Centre for the Study of Liver Diseases at the University of Hong Kong. The second generation of cancer drugs will also go through similar testing stages in the years ahead.

The discovery of this new drug is supported by research funding from the Lo Ka Chung Charity Foundation and the Simatelex Charitable Foundation. The research work is being undertaken at the University’s Lo Ka Chung Centre for Natural Anti-Cancer Drug Development, which was set up in December 2006 with a generous donation of HK$20 million from Mr Lo.

This innovation, together with the descriptions of five other intriguing research projects, are being put on public display at the "PolyU Achievements Exhibition" which runs from 6 to 9 April on the university campus.

Evelyn Chan | Research asia research news
Further information:
http://www.researchsea.com
http://www.polyu.edu.hk/cpa/polyu/hotnews/details_e.php?year=2009&news_id=1609

More articles from Life Sciences:

nachricht Link Discovered between Immune System, Brain Structure and Memory
26.04.2017 | Universität Basel

nachricht Researchers develop eco-friendly, 4-in-1 catalyst
25.04.2017 | Brown University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

Scientist invents way to trigger artificial photosynthesis to clean air

26.04.2017 | Materials Sciences

Ammonium nitrogen input increases the synthesis of anticarcinogenic compounds in broccoli

26.04.2017 | Agricultural and Forestry Science

SwRI-led team discovers lull in Mars' giant impact history

26.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>